A Novel Epithelial-Mesenchymal Transition Gene Signature Correlated With Prognosis, and Immune Infiltration in Hepatocellular Carcinoma

被引:6
|
作者
Kong, Weihao
Mao, Zhongxiang
Han, Chen
Ding, Zhenxing
Yuan, Qianqian
Zhang, Gaosong
Li, Chong
Wu, Xuesheng
Chen, Jia
Guo, Manyu
Hong, Shaocheng
Yu, Feng
Liu, Rongqiang
Wang, Xingyu
Zhang, Jianlin
机构
[1] Department of Emergency Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei
[2] Registration Review Department, Anhui Center for Drug Evaluation & Inspection, Hefei
[3] Department of Emergency Medicine, The First Affiliated Hospital of Anhui Medical University, Hefei
[4] Department of Biochemistry & Molecular Biology, School of Basic Medicine, Anhui Medical University, Hefei
[5] Department Ultrasound, The First Affiliated Hospital of Anhui Medical University, Hefei
[6] The First Clinical Medical College, Anhui Medical University, Anhui Medical University, Hefei
[7] Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou
关键词
epithelial-mesenchymal transition; gene signature; TCGA; GEO; ICGC; hepatocellular carcinoma; R PACKAGE; METAANALYSIS;
D O I
10.3389/fphar.2022.863750
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Although many genes related to epithelial-mesenchymal transition (EMT) have been explored in hepatocellular carcinoma (HCC), their prognostic significance still needs further analysis.Methods: Differentially expressed EMT-related genes were obtained through the integrated analysis of 4 Gene expression omnibus (GEO) datasets. The univariate Cox regression and Lasso Cox regression models are utilized to determine the EMT-related gene signature. Based on the results of multivariate Cox regression, a predictive nomogram is established. Time-dependent ROC curve and calibration curve are used to show the distinguishing ability and consistency of the nomogram. Finally, we explored the correlation between EMT risk score and immune immunity.Results: We identified a nine EMT-related gene signature to predict the survival outcome of HCC patients. Based on the EMT risk score's median, HCC patients in each dataset were divided into high and low-risk groups. The survival outcomes of HCC patients in the high-risk group were significantly worse than those in the low-risk group. The prediction nomogram based on the EMT risk score has better distinguishing ability and consistency. High EMT risk score was related to immune infiltration.Conclusion: The nomogram based on the EMT risk score can reliably predict the survival outcome of HCC patients, thereby providing benefits for medical decisions.
引用
收藏
页数:14
相关论文
共 50 条
  • [31] Identification of a Novel Epithelial-Mesenchymal Transition Gene Signature Predicting Survival in Patients With HNSCC
    Xin, Wei
    Zhao, Chaoran
    Jiang, Longyang
    Pei, Dongmei
    Zhao, Lin
    Zhang, Chengpu
    PATHOLOGY & ONCOLOGY RESEARCH, 2021, 27
  • [32] Epithelial-mesenchymal transition-related gene prognostic index and phenotyping clusters for hepatocellular carcinoma patients
    Wang, Xiaojing
    Zeng, Wangyuan
    Yang, Lu
    Chang, Tanjie
    Zeng, Jiangzheng
    CANCER GENETICS, 2023, 274 : 41 - 50
  • [33] Development and Validation of a Novel Gene Signature for Predicting the Prognosis of Idiopathic Pulmonary Fibrosis Based on Three Epithelial-Mesenchymal Transition and Immune-Related Genes
    Zheng, Jiafeng
    Dong, Hanquan
    Zhang, Tongqiang
    Ning, Jing
    Xu, Yongsheng
    Cai, Chunquan
    FRONTIERS IN GENETICS, 2022, 13
  • [34] EDIL3 is a novel regulator of epithelial-mesenchymal transition controlling early recurrence of hepatocellular carcinoma
    Xia, Hongping
    Chen, Jianxiang
    Shi, Ming
    Gao, Hengjun
    Sekar, Karthik
    Seshachalam, Veerabrahma Pratap
    Ooi, London Lucien P. J.
    Hui, Kam M.
    JOURNAL OF HEPATOLOGY, 2015, 63 (04) : 863 - 873
  • [35] Osteopontin promotes epithelial-mesenchymal transition of hepatocellular carcinoma through regulating vimentin
    Dong, Qiongzhu
    Zhu, Xuchao
    Dai, Chun
    Zhang, Xiaofei
    Gao, Xiaomei
    Wei, Jinwang
    Sheng, Yuanyuan
    Zheng, Yan
    Yu, Jian
    Xie, Lu
    Qin, Yi
    Qiao, Peng
    Zhou, Chuang
    Yu, Xinxin
    Jia, Huliang
    Ren, Ning
    Zhou, Haijun
    Ye, Qinghai
    Qin, Lunxiu
    ONCOTARGET, 2016, 7 (11) : 12997 - 13012
  • [36] Expression of the serum response factor in hepatocellular carcinoma: Implications for epithelial-mesenchymal transition
    Park, Min Young
    Kim, Kyung Ryoul
    Park, Ho Sung
    Park, Byung-Hyun
    Choi, Ha Na
    Jang, Kyu Yun
    Chung, Myoung Ja
    Kang, Myoung Jae
    Lee, Dong Geun
    Moon, Woo Sung
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2007, 31 (06) : 1309 - 1315
  • [37] Construction and validation of a novel signature based on epithelial-mesenchymal transition–related genes to predict prognosis and immunotherapy response in hepatocellular carcinoma by comprehensive analysis of the tumor microenvironment
    Biao Gao
    Yafei Wang
    Shichun Lu
    Functional & Integrative Genomics, 2023, 23
  • [38] Sorafenib inhibits macrophage-mediated epithelial-mesenchymal transition in hepatocellular carcinoma
    Deng, Yan-Ru
    Liu, Wen-Bin
    Lian, Zhe-Xiong
    Li, Xingsheng
    Hou, Xin
    ONCOTARGET, 2016, 7 (25) : 38292 - 38305
  • [39] Hook1 inhibits malignancy and epithelial-mesenchymal transition in hepatocellular carcinoma
    Sun, Xu
    Zhang, Qi
    Chen, Wei
    Hu, Qida
    Lou, Yu
    Fu, Qi-Han
    Zhang, Jing-Ying
    Chen, Yi-Wen
    Ye, Long-Yun
    Wang, Yi
    Xie, Shang-Zhi
    Hu, Li-Qiang
    Liang, Ting-Bo
    Bai, Xue-Li
    TUMOR BIOLOGY, 2017, 39 (07) : 1 - 8
  • [40] Identification of an Epithelial-Mesenchymal Transition-Related Long Non-coding RNA Prognostic Signature to Determine the Prognosis and Drug Treatment of Hepatocellular Carcinoma Patients
    Huang, Shenglan
    Li, Dan
    Zhuang, Lingling
    Zhang, Jian
    Wu, Jianbing
    FRONTIERS IN MEDICINE, 2022, 9